El Vínculo El Vínculo.
Awarded European Union SuppliesFramework agreement

MEDICAMENTE ANTINEOPLAZICE 1

Buyer: SPITALUL CLINIC C.F. CLUJ

Published
12 July 2024
Procedure
Open procedure
Notice number
00417662-2024
Reference
275d3d9b-78ea-4a89-b087-65087136dd7e
Official source
Official source

CPV codes

Description

Medicamente antineoplazice 1. A se vedea Caietul de sarcini.Autoritatea contractanta va raspunde in mod clar si complet tuturor solicitarilor de clarificare/informatiilor suplimentare in a 12-a zi inainte de termenul limita stabilit pentru depunerea ofertelor, Nr zile pana la care se pot solicita clarificari inainte de data de depunere a ofertelor este 20

Lots (22)

LotDescriptionCPV codeAmount
1 AFLIBERCEPTUM - flc.100 mg
RO113
33652100 Agentes antineoplásicos
2 AFLIBERCEPTUM - flc.200 mg
RO113
33652100 Agentes antineoplásicos
3 AVELUMABUM - 1 flacon x 10 ml conc. pt. sol. perf. 200 mg
RO113
33652100 Agentes antineoplásicos
4 BEVACIZUMABUM - inovativ - fl.100 mg
RO113
33652100 Agentes antineoplásicos
5 BEVACIZUMABUM - inovativ - fl.400 mg
RO113
33652100 Agentes antineoplásicos
6 BEVACIZUMABUM - biosimilar - fl.100 mg
RO113
33652100 Agentes antineoplásicos
7 BEVACIZUMABUM - biosimilar - fl.400 mg
RO113
33652100 Agentes antineoplásicos
8 CALCII FOLINAS - flc.10mg/ml;fl.10 ml
RO113
33652100 Agentes antineoplásicos
9 CETUXIMABUM - sol.perf.5mg/ml
RO113
33652100 Agentes antineoplásicos
10 DURVALUMAB - 1 flac.2,4 ml conc.(120mg)
RO113
33652100 Agentes antineoplásicos
11 DURVALUMAB - 1 flac.10 ml conc.(500mg)
RO113
33652100 Agentes antineoplásicos
12 IRINOTECANUM* LIPOSOMALUM - 4,3mg/ml x10ml
RO113
33652100 Agentes antineoplásicos
13 PACLITAXELUM - fl. 30 mg
RO113
33652100 Agentes antineoplásicos
14 PANITUMUMABUM - flc.100 mg
RO113
33652100 Agentes antineoplásicos
15 PANITUMUMABUM - flc.400mg
RO113
33652100 Agentes antineoplásicos
16 PEMETREXED - flac. 500 mg
RO113
33652100 Agentes antineoplásicos
17 PERTUZUMABUM - flc.420 mg
RO113
33652100 Agentes antineoplásicos
18 TOPOTECAMUM - fl. 4 mg
RO113
33652100 Agentes antineoplásicos
19 TRASTUZUMABUM - flc.150 mg
RO113
33652100 Agentes antineoplásicos
20 TRASTUZUMABUM EMTANSINUM - flc.100mg/15ml
RO113
33652100 Agentes antineoplásicos
21 TRASTUZUMABUM DERUXTECANUM - flc.100mg/10ml
RO113
33652100 Agentes antineoplásicos
22 VINORELBINUM - flac. 10 mg
RO113
33652100 Agentes antineoplásicos

Award criteria

Awards

Awarded toAmountDate
DR.MAX 2,974,516 RON
FARMACEUTICA REMEDIA DISTRIBUTION & LOGISTICS S.R.L. 2,955,014 RON
DR.MAX 1,003,288 RON
DR.MAX 857,034 RON
FARMEXIM S.A. 511,123 RON
DR.MAX 200,322 RON
BIO EEL S.R.L. 188,220 RON
DR.MAX 149,082 RON
FARMEXIM S.A. 128,880 RON
DR.MAX 127,797 RON

Official publications

Other tenders from SPITALUL CLINIC C.F. CLUJ

Frequently asked questions

Who is the buyer of this tender?
The contracting authority is SPITALUL CLINIC C.F. CLUJ (European Union).
How can I bid for public tenders in European Union?
Bids are submitted through the official procurement portal of European Union. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.